333
Anti-HIV Cytotoxic T Lymphocytes (CTL) in Cerebrospinal Fluid and Peripheral Blood of Immune Controllers of Plasma Viremia
S Kalams, K Brady, B Simmons, J Conrad, S Lorey, S Montgomery, J Nicotera, and David W Haas*
Vanderbilt Univ Sch of Med, Nashville, TN, US
Background: HIV replication in the central nervous
system occurs during acute infection and advanced AIDS, but may not occur in
some asymptomatic individuals with chronic, untreated HIV infection. HIV-specific
T cells partially control systemic HIV replication, but their role in the central
nervous system is uncertain. We characterized anti-HIV CD8+ T cells in
cerebrospinal fluid (CSF) and peripheral blood mononuclear cells (PBMC) among individuals
with immune control of systemic HIV replication without ART.
Methods: We collected CSF mononuclear
cells and PBMC from 3 asymptomatic adults with chronic HIV infection, not
receiving ART, and without CSF pleocytosis (≤3 cells/μL). CSF was collected on ice, spun at 200
X g for 10 minutes at 4 °C, and cells were resuspended in RPMI medium. Approximately 80% of CSF cells
were expanded ex vivo for 10 to 14 days with an anti-CD3 monoclonal
antibody. Epitope recognition by expanded cells was assessed by ELISpot and intracellular cytokine staining. We evaluated responses
to individual epitopic peptides (8 to 11 amino acids in length), and to HIV
peptide pools derived from Gag, Pol, Nef, and Env (18 amino acids overlapping by 11). To facilitate
comparisons, CSF and PBMC cells were processed identically, including ex
vivo expansion from the same number of PBMC as CSF cells.
Results: Peripheral CD4 cell counts in the 3
subjects were >800 cells/mm3, and plasma HIV-1 RNA was <3000 copies/mL.
Each 40-mL CSF specimen provided 80,000 to 130,000 mononuclear cells, which
were readily expanded ex vivo to
>5 x 106 cells after 10 to 14 days in culture. ELISpot using 10 to 25 peptides representing known CD8+
T-cell epitopes readily detected CD8+ T
cell responses from expanded CSF T cells, the repertoire of epitope recognition
being qualitatively similar to PBMC. In 2 subjects, response magnitudes were greater
in CSF; 2 subjects possessed an HLA B57 allele (often associated with slower
disease progression). Cytotoxic T lymphocytes (CTL) in
CSF and blood from these subjects recognized KF11, a common HLA B57-restricted
epitope and responses were confirmed by intracellular cytokine staining. In 1 subject
the percentage of expanded CD8+ T cells specific for KF11 was 24.2% from
CSF vs.\ 2.7% from PBMC.
Conclusions: Epitope-specific CD8+
T cells can be readily expanded from CSF of asymptomatic HIV-infected
individuals, even without CSF pleocytosis. Anti-HIV CTL responses may play an
important role in controlling HIV replication in the central nervous
system among individuals
with immunologic control of plasma viremia without ART.
|